THE USE of hyperbaric oxygen as an adjuvant to clinical radiotherapy is of great interest. This has been stimulated by the demonstration of many hypoxic, and consequently radio-resistant, cells in a wide range of animal tumors (1) (2) (3) (4) . Although such cells have not been established in any human tumor, histologic and polarographic studies suggest a situation similar to that in the experimental animal (5, 6) . Recent experiments showed that, during fractionated radiotherapy, the oxygenation of originally hypoxic cells is partially improved; this process usually is termed "reoxygenation" (1, (7) (8) (9) . Also, there is some evidence that "chronically" hypoxic cells, i.e., cells that remain hypoxic throughout treatment, would be expected to have a reduced ability to repair radiation-induced sublethal damage (10) . Both these factors tend to reduce the importance of hypoxic cells in determining the tumor's resistance to irradiation. Perhaps suitable schemes of fractionation could overcome completely the problem of such cells and make use of adjuvants, such as hyperbaric oxygen, unnecessary.
A study of the response of transplanted C3H mouse mammary carcinoma to both a single dose and to 10 equal daily fractions of X-rays was made by Suit and Maeda (1) . They showed that, although oxygenation apparently improved with the fractionated treatment, the dose to achieve 50% local control of the tumors was still determined by viable hypoxic cells. They also showed that the effectiveness of hyperbaric oxygen breathing increased greatly when combined with the IO-dose treatment as compared with a single exposure. This indicated a considerable therapeutic gain. As an extension of this study, it was of interest to know whether the improved effectiveness of hyperbaric oxygen was uniform throughout the 10 treatments. A possible nonuniformity in effectiveness could be brought about by variation in the extent of reoxygenation between fractions as well as by damage to the tumor blood vasculature. Information on this subject could have implications to clinical radiation therapy, because it would help predict the most effective and economical way in which therapeutic adjuvants such as high-pressure oxygen and possibly high linear energy transfer (LET) radiations might be used.
MATERIALS AND METHODS
Animal tumor .rystem.-Third-generation isotransplants of a spontaneous C3H/He mouse mammary carcinoma were made from cell suspensions prepared from freshly excised second-generation transplants; an inoculum of 5-10 JL I suspension containing 5-10 X 10 5 viable tumor cells was injected into the muscle mass of the right leg. The origin of the tumor, techniques of storage in liquid nitrogen, and preparation of the cell suspensions are detailed in (1, 11) .
Irradiation .rystem.-Local tumor irradiations were performed with a specially designed 137Ce unit consisting of 2 opposed sources treating a 3-cm diameter circular field at a dose rate of approximately 1050 rads/rninute at the center of the tumor. Variation in dose rate across the tumor has been estimated to be ±3%. At irradiation, mice were anesthetized with an intraperitoneal injection of 0.07 mg pentobarbitol/g body weight and placed into specially constructed brass chambers so that the physical setup for each type of irradiation would be uniform. Tumors were irradiated under conditions of either: a) air breathing at normal atmosphere pressure, or b) pure oxygen breathing at a gauge pressure of 30 psi (0 2 , 30 psi), the oxygen maintained for 15 minutes before and during the exposure period.
Dose-response assay system.-After transplantation, mice were randomly assigned to dose groups in I of 4 dose-response assays. When the tumors had reached a mean diameter of 8± I mm (corresponding to a tumor vol of =250 mm'') , treatment was initiated; this consisted of 10 equal dose fractions, with 24 hours between fractions. Irradiations were given under one of the following conditions: Tumor diameters were measured during treatment, then weekly for 120 days. Mice surviving this period without recurrence were scored as local controls. Mice dying before the end of the observation period without recurrence were eliminated from the final analysis; the remainder showed local recurrence and were usually killed when the tumor diameter reached a mean value of 15 mm.
The fractions of mice in each dose group, which were locally controlled, were analyzed to yield the most probable dose required to control 50% of each tumor population. This dose-the TCD50/l20 days-and an estimate of its 95% confidence limits were obtained with a modified form of logit analysis developed by R. Wette and described in (11) .
RESULTS AND DISCUSSION
TCD50/120 day values for each of the 4 assay groups are given in table 1. The values of TCD50 for completely O 2 , 30 psi, or air conditions (groups 1, 4) differed from those orignially obtained by Suit and Maeda in being =20% higher (1). This result was due mainly to a significantly lower relative biologic effectiveness of the 137Ce 'Y-rays compared with the 250 kV X-rays used in the earlier work. However, the results were qualitatively similar in that they showed significant increase in effectiveness due to the use of high pressure oxygen in combination with the fractionated irradiation. This was evidenced by the increase in the ratio of TCD50 air/TCD50 O2, 30 psi, from a value normally obtained with single doses of approximately 1.2 (1, 12) to a value of approximately 1.7 (table 2). The TCD50 values obtained with the mixed treatments were not significantly different from each other, but both were significantly smaller than the "air only" value. They were only slightly (not significantly) higher than the results obtained when oxygen was used for all 10 fractions. There was a suggestion that application of high pressure oxygen for the first 5 treatments was slightly more effective than application during the second half. Estimates of relative changes in tumor diameter, measured for each group at the times of the first, fifth, and tenth exposure, are plotted in text-figure 1. The measurements were made to test for the possibility of a correlation between the effectiveness of each mode of treatment and the volume response. For this reason, only data from tumors given doses close to the appropriate TCD50 value for each group were analyzed. Although the data showed a good deal of scatter, an interesting pattern did emerge. Tumors irradiated entirely under air-breathing conditions tended to increase in volume during treatment, whereas tumors irradiated entirely under hyperbaric oxygen-breathing conditions showed little, if any, change. Tumors subjected to the mixed treatments showed no distinct trend, though all receiving hyperbaric oxygen for at least part of their treatment were smaller at the end of irradiation than those entirely under air-breathing conditions.
Administration of high-pressure oxygen during either the first or the second half of the lO-fraction treatment produced a significant improvement in response over air exposures alone. This result indicates the presence of large numbers of hypoxic cells at all stages of treatment. The similarity of TCD50 values for the "mixed" courses indicates no particular advantage from applying high-pressure oxygen at an early or late stage of the treatment.
In their original paper, Suit and Maeda considered a model tumor in which response is determined. by the survival of a population consisting of 20% hypoxic and 80% well-oxygenated, or aerobic cells. Cell killing was described by a multitarget dose-survival relationship and between each dose fraction a proportion, T, of viable hypoxic cells was transferred to the aerobic compartment. Using this model, they showed that the response of mouse mammary tumors to 10 daily X-ray treatments was compatible with a transfer factor of 22% (T=O.22). From the same model, but with cell survival parameters appropriate for 137CS 'Y-radiation, a similar value of T (i.e., 0.22) can be used to account for the response of tumors to 10 daily doses given under air-breathing conditions (table 3a) second half, the relative value of 1 is increased significantly in both cases. When the second half of treatment is given under air-breathing conditions, the value of 1 is increased from 0.22 to 0.5 (i.e., to a value similar to that for 0z, 30 psi, conditions), whereas for 02' 30 psi, conditions, T is increased from a "control" value of 0.55 to 0.8. Such an analysis is obviously oversimplified, but does strongly suggest that reoxygenation in terms of transfer of cells from a hypoxic to a well-oxygenated status is more effective during the second half of treatment.
From the tumor diameter measurements (text- fig.   I ), a simple correlation cannot be obtained between tumor response (in terms of TCD50) and relative change in volume The slight, progressive increase in size during the air-breathing treatments may be associated with the poor extent of transfer of cells from a hypoxic to an aerobic environment, whereas for O 2,30 psi, treatments the increased transfer factor may
ing conditions, the model indicates that a relatively greater transfer factor (1) is appropriate, viz., a value of 1=0.55 (table 3a) . The values of 1 obtained with this model indicate that, even with hyperbaric oxygen, the tumors never become as well oxygenated during treatment as before-in terms of restoring the proportion of hypoxic cells to its original value. To achieve this situation, 1 values of =0.7 and 0.98 for air and oxygen treatments, respectively, would be necessary. It is therefore of considerable interest that even a relatively slight improvement in oxygenation extended over several fractions can produce a large improvement in tumor sensitivity. An apparent improvement in effectiveness of fractionated radiation treatment could be at least partly attributable to a redistribution of cells throughout their generation cycle after partial synchrony of cells in a relatively radioresistant phase. Incorporation of this effect into the present model is difficult, if valid, due to limited knowledge concerning agedependent radiosensitivity and redistribution for tumor cells in vivo. Young and Fowler (13) have discussed fully the implications of this effect based on data obtained from in vitro experiments. They concluded, if several fractions were given at regular intervals, the effects of partial synchronization would be expected to average out. For these reasons, the effects of cell age distribution on tumor response are not taken into account, and changes in sensitivity are attributed entirely to redistributions of oxygen.
If the same model is applied to the mixed courses of treatment, the observed values of TCD50 cannot be explained by simply assuming the same rate of transfer of hypoxic cells in each half of the treatments as for 10 fractions given under uniform conditions (tables 3b, 3c). Alternatively, if it is assumed that, during the first half of each mixed course, the transfer factor is the same as for the appropriate uniform course (i.e., 1 = 0.22 for air, 0.55 for 02' 30 psi), during the be associated with the observation of relatively little or no change in size during treatment. However, since the tumor diameter measurements varied only slightly, it seems unlikely that relative tumor volume changes have a major function in determining the response to treatment with -y-rays combined with high-pressure oxygen.
For the experimental system used, the combination of fractionated radiotherapy and hyperbaric oxygen breathing produces a significant improvement in response compared with air breathing. Further, because of a highly efficient transfer of cells from a hypoxic to an oxygenated status with 02' 30 psi, the addition of oxygen for only half the total course of treatment is capable of producing a response closely approaching that obtained when oxygen is given with all exposures to radiation. An attempt to correlate the transfer of cells into a status of improved oxygenation with changes in tumor volume during treatment was inconclusive, but suggested that changes in tumor volume have a small, but definite part in this system.
